Alembic Pharma shares gain after drugmaker gets USFDA approval for cancer treatment drug

With this approval, Alembic Pharma now has a cumulative total of 236 ANDA approvals from the USFDA, including 218 final approvals and 18 tentative approvals.

Leave a Reply

Your email address will not be published. Required fields are marked *